Injectable Scaffolds represent a cutting-edge approach in regenerative medicine, offering a versatile solution for tissue engineering and repair. These scaffolds, typically composed of biocompatible materials, can be injected directly into targeted areas of the body, providing a minimally invasive means to support tissue regeneration. The scaffolds serve as a three-dimensional framework that facilitates cell adhesion, proliferation, and differentiation, promoting the formation of new tissue. Common materials include biodegradable polymers, hydrogels, and nanofibrous structures. Injectable scaffolds find applications in various medical fields, such as orthopedics, cardiology, and dermatology, addressing tissue damage, degeneration, or injury. In orthopedics, they may aid in cartilage or bone regeneration, while in cardiology, they can support cardiac tissue repair following a heart attack. The injectability of these scaffolds allows for precise placement, enabling clinicians to target specific anatomical locations. Incorporating bioactive agents, growth factors, or cells into the scaffold enhances its regenerative potential. However, challenges include ensuring the scaffold's stability and controlling its degradation rate. The development of injectable scaffolds represents a promising frontier, bridging the gap between traditional tissue engineering approaches and clinical applications, offering a potential revolution in the treatment of various medical conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States